View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 13, 2020

Coronavirus: CDC finds some test kits sent to states are faulty

The US Centers for Disease Control and Prevention (CDC) has found that some coronavirus test kits delivered to state laboratories are faulty.

Follow the latest updates of the outbreak on our timeline.

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

The US Centers for Disease Control and Prevention (CDC) has found that some coronavirus test kits delivered to state laboratories are faulty.

The test kits were delivered to enable states to carry out testing locally rather than transporting samples to CDC headquarters in Atlanta, expediting the diagnosis process.

The public health institute is working to ship replacements, report Reuters.

After receiving the test kits, state labs must verify them to ensure that they function correctly.

However, some public health labs reported that during a routine verification process, the kits provided inconclusive results.

In a press conference, CDC National Center for Immunization and Respiratory Diseases director Dr Nancy Messonnier said: “When a state gets the test kits, they have to verify that it works the same in their lab that it worked at CDC.

“And when some states were doing this, we received feedback that they weren’t, that it wasn’t working as expected, specifically some public health labs at states were getting inconclusive results and what that means is that test results were not coming back as false positive or false negatives but they were being read as inconclusive.”

Messonnier speculates that an issue with one of three assays and inconsistent performance by a reagent are likely behind the inconclusive results.

However, officials did not specify how many kits were faulty.

Meanwhile, the death toll due to coronavirus outbreak jumped to 1,369 with 254 new fatalities reported at the end of 12 February.

Recently, the virus was officially named Covid-19 by the World Health Organization (WHO).

The total number of Covid-19 cases in the US is 14.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU